About Ryse Health
Ryse Health is a private company based in Baltimore, Maryland, incorporated in 2020 in Delaware. It has reported $13,027,484 raised in three offerings on Form D since November 2021. Its chief executive is Richard Gurley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | Apr 7, 2025 | $900,000of $2.0M target | 2 | $450K | EquityRule 506(b) | Form D ↗ |
| Dec 21, 2022 | Jan 3, 2023 | $9,793,484of $11.8M target | 27 | $362K | EquityRule 506(b) | Form D ↗ |
| Oct 29, 2021 | Nov 12, 2021 | $2,334,000of $2.5M target | 7 | $333K | OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $13,027,484 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ryse Health's Form D filed Apr 7, 2025.
PJ
Pankaj Jethwani
Director
RG
Richard Gurley
Chief Executive Officer and director
ED
Eric Dobosh
Director
RT
Ryan Tyner
Director
Earlier filings also listed Pat Wilson (director, last listed Jan 2023) and Erin Kane (executive officer, director and promoter, last listed Jan 2023).